The Marked Chart Wire · Business
AstraZeneca
AstraZeneca Q3 profit rises, reconfirms full-year guidance
AstraZeneca reported third-quarter profit of $3.12 billion, up from $2.53 billion a year earlier. The company reiterated its full-year 2026 revenue and core EPS targets.
